Geron Presents Data at ISSCR Showing That Its Embryonic Stem Cell Therapeutic for Heart Failure Evades Direct Attack by the Human Immune System > Morton Cure Paralysis Fund

Geron Presents Data at ISSCR Showing That Its Embryonic Stem Cell Therapeutic for Heart Failure Evades Direct Attack by the Human Immune System

MENLO PARK, Calif.--(BUSINESS WIRE)--Geron Corporation (Nasdaq:GERN) today announced the presentation of research studies indicating that GRNCM1, the company’s human embryonic stem cell (hESC)-based therapeutic for the treatment of heart failure, evades direct attack by...

posted @ Tuesday, July 08, 2008 11:31 AM by pmorton

Previous Page | Next Page